Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 440 participants.
Also called NCT04088513
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 440 participants
- Registry
-
NCT04088513
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04088513. Randomized; quadruple masking; primary purpose treatment. Start 2020-01-22 (actual); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)
- Acronym
- SAST
- Condition
- G6PD Deficiency
- Condition
- Stroke
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- First Affiliated Hospital, Sun Yat-Sen University
Record details
- Record id
cardio:ct-nct04088513- Content hash
22338a59ab990d434ba6ab44b32a545c54fb99079ce139bcb81bad7ccf74c239